PIAS3 and neoplasm: Early studies in glioblastoma multiforme (GBM) and breast cancer have indicated that in tumor cells derived from these cancers, PIAS3 expression is suppressed by proteasomal degradation (Borghouts et al., 2010; Brantley et al., 2008).